This company has created a device that can save a life. Momentum continues to build as this company moves deeper into clinical trials and closer to possible FDA approval. Investors are taking notice & we have the FULL details! Check This Out!
As part of its merriment of International Women’s Day, Accenture Plc (NYSE:ACN) reported that women now comprise for 41% of its global workforce compared to just under 40% in June 2017, when the firm first reported its objective of attaining a gender-balanced workforce by 2025…Read More Now
ENSCO PLC (NYSE:ESV) posted a loss of $0.49 a share for Q4 2017 versus earnings of $0.13 a share in the same period, a year earlier. Results from discontinued operations came at zero cents per share in Q4 2017 versus EPS of $0.03 in Q4 2016…Read More Now